» Articles » PMID: 4621242

Somatostatin Inhibits Insulin and Glucagon Release by Monolayer Cell Cultures of Rat Endocrine Pancreas

Overview
Journal Life Sci
Publisher Elsevier
Date 1974 Dec 1
PMID 4621242
Citations 11
Authors
Affiliations
Soon will be listed here.
Citing Articles

Glucagon's Metabolic Action in Health and Disease.

Zeigerer A, Sekar R, Kleinert M, Nason S, Habegger K, Muller T Compr Physiol. 2021; 11(2):1759-1783.

PMID: 33792899 PMC: 8513137. DOI: 10.1002/cphy.c200013.


Basal hypersecretion of glucagon and insulin from palmitate-exposed human islets depends on FFAR1 but not decreased somatostatin secretion.

Kristinsson H, Sargsyan E, Manell H, Smith D, Gopel S, Bergsten P Sci Rep. 2017; 7(1):4657.

PMID: 28680093 PMC: 5498543. DOI: 10.1038/s41598-017-04730-5.


Ontogenetic appearance of immunoreactive endocrine cells in rat pancreatic islets.

Yoshinari M, Daikoku S Anat Embryol (Berl). 1982; 165(1):63-70.

PMID: 6128945 DOI: 10.1007/BF00304583.


Inhibitory effect of somatostatin on the aldosterone response to angiotensin II: in vitro studies.

Boscaro M, Scaroni C, Edwards C, Mantero F J Endocrinol Invest. 1982; 5(3):173-7.

PMID: 6125538 DOI: 10.1007/BF03349475.


Studies on insulin secretion by monolayer cultures of normal and tumorous human pancreatic cells. Effects of glucose, somatostatin and SMS 201-995.

Oosterom R, Verleun T, Uitterlinden P, Bruining H, Bruining G, Verschoor L J Endocrinol Invest. 1987; 10(6):547-52.

PMID: 2894388 DOI: 10.1007/BF03346991.